Article info
PDFNeurodegeneration
Research paper
Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study
- Correspondence to Professor Gen Sobue, Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466 8550, Japan; sobueg{at}med.nagoya-u.ac.jp
Citation
Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study
Publication history
- Received March 8, 2017
- Revised May 3, 2017
- Accepted June 5, 2017
- First published August 5, 2017.
Online issue publication
February 23, 2018
Article Versions
- Previous version (12 December 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.